This breakthrough not only elucidates the critical molecular mechanism underlying the neuroprotective effects of GLP-1R agonists but also provides a new direction for developing metabolic regulation-based targeted therapeutic strategies for AD
Uptake in Britain is expected to rise further with the arrival this week of GLP-1s in pill form, with UK pharmacies preparing for a rise in requests for the once-a-day Wegovy tablet now only available on private prescription
But users also risk potential legal consequences: For example, in Texas, possession of drugs that are unsafe for self-medication can be considered a misdemeanor offense
In these cases, aggressive surgery, followed by radioactive iodine therapy, can provide long-term remission
Currently, intense media attention and influencer promotion, coupled with robust marketing tactics, have led to an increase in the demand for GLP-1 RAs, resulting in global shortages of these medications